Skip to content

CDR

Walgreens sees drop in 3Q earnings

Walgreens sees drop in 3Q earnings

Despite an uptick in sales, Walgreen Co. saw its fiscal 2010 third-quarter earnings drop due in part to special charges and the loss of a key tax benefit. The drug store chain said Tuesday that net earnings for the quarter ended May 31 totaled $463 million, or 47 cents per diluted share,

Kowa Pharmaceuticals, Lilly launch Livalo

Kowa Pharmaceuticals America Inc. and Eli Lilly and Co. have rolled out cholesterol-lowering drug Livalo to retail pharmacies in the United States. The drug makers said Monday that Livalo (pitavastatin) is available in 1 mg, 2 mg and 4 mg tablets.

Health Mart honors merchandising partner SPAR Group

Health Mart has named retail merchandising and marketing services provider SPAR Group Inc. as its Consumer Products Group Partner of the Year. Tarrytown, N.Y.-based SPAR Group said Friday it’s the inaugural recipient of the award from the drug store franchise, which is a subsidiary of McKesson Corp.

Kimberly-Clark makes executive moves

Kimberly-Clark Corp. has made executive changes that it said will sharpen its focus on continuous improvement, global sourcing and sustainability. The company also elected a new board member.

FDA issues alert on fraudulent Tamiflu

The Food and Drug Administration is warning consumers about a potentially harmful product represented as "Generic Tamiflu" that’s sold on the Internet. There’s no FDA-approved generic drug for the prescription product Tamiflu, the agency reported Thursday.

Walgreens, CVS Caremark settle PBM dispute

Walgreens, CVS Caremark settle PBM dispute

Ending what had been shaping up to be a standoff, Walgreen Co. and CVS Caremark Corp. have reached an agreement in which Walgreens will continue as a provider in the Caremark pharmacy benefit management retail network for current, new and renewal plans. The two drug store chain rivals announced

Lawmakers: Rx unfairly targeted for DME costs

Lawmakers: Rx unfairly targeted for DME costs

Two members of Congress have asked the Centers for Medicare and Medicaid Services (CMS) to stop aggressive efforts by Medicare Part B durable medical equipment (DME) contractors to recoup costs from pharmacies, according to the National Community Pharmacists Association.

UCB launches Vimpat oral solution

UCB has rolled out an oral solution formulation of Vimpat C-V, an antiepileptic drug for add-on treatment of partial-onset seizures in people with epilepsy age 17 years and older. The company said Monday that Vimpat (lacosamide) 10 mg/mL solution is now available in U.S.